Filter posts

The State Of Biotech Regulations In 2018 — An Ag Policy Expert’s Perspective

At GMO Answers, we focus primarily on public consumer education and awareness campaigns. Our materials …

New Infographic: Balancing Need for Innovation with Competition

It is an underreported fact that the time it takes for a generic medicine to …

Save the Date: Human Genome Editing Webinar with NAS/NAM, FDA on February 22

DNA defines who we are. And like anything else, sometimes there are mistakes – mutations …

FDA’s No. 2 Official Sounds Off on Right to Try, Opioid Crisis

During his first State of the Union address two weeks ago, President Donald Trump expressed …

Steps to Improve Competition in the Prescription Drug Marketplace

Recently on BIOtechNOW, we shared Three Encouraging Steps on Prescription Drug Costs which looked at recent …

FDA’s Historic Gene Therapy Approvals Could Be Beginning of the End of Blood Cancer

In his inaugural address this June as chairman of the world’s largest biotechnology industry group, …

Expanded Access – It Continues to Make Headlines

The recent Senate passage of S. 204, the Trickett Wendler, Frank Mongiello, and Jordan McLinn …

Agriculture 101: Asking Hard Questions And Digging For Answers

Headed back to school? So is this teacher, who shares how she encourages her students …

Three Encouraging Steps on Prescription Drug Costs

It’s a refrain you hear often in the news: Drug costs are soaring and nothing …

ICYMI: Reagan-Udall Foundation Launches Expanded Access Navigator for Patients and Physicians

The Reagan-Udall Foundation for the Food and Drug Administration (FDA) recently announced the release of …